Industry Experts

Nisit is the co-founder and Chief Executive Officer of Cycuria. Before establishing Cycuria, he founded iOmx Therapeutics in 2016, a clinical-stage immuno-oncology biotech company based in Munich, Germany, that successfully raised over €110 million in venture financing. Nisit has held pivotal roles within iOmx, beginning as the Head of Research and advancing to Chief Technology Officer and Managing Director.

Nisit completed his Bachelor’s degree in Biotechnology at Vellore Institute of Technology (VIT University) in India. He then pursued a Masters by Research in Biomedical Sciences at the University of Edinburgh in the UK, followed by a PhD in Translational Immunology from the German Cancer Research Center (DKFZ) in Heidelberg, Germany, under the mentorship of Prof. Dr. Philipp Beckhove. He was PI for a joint research project between the German Cancer Research Center and Bayer Health Care from 2014-2016.

In 2016, with an impressive €40 million Series A funding, Nisit co-founded iOmx Therapeutics. He is a passionate entrepreneur with deep expertise in platform technologies and early-stage oncology drug discovery and development. Nisit is the lead inventor on several granted and filed patents and has authored numerous high-impact scientific publications in the field of cancer immunotherapy.